Abstract:The use of existing mouse models in cancer research is of utmost importance as they aim to explore the casual link between candidate cancer genes and carcinogenesis as well as to provide models to develop and test new therapies. However, faster progress in translating mouse cancer model research into the clinic has been hampered due to the limitations of these models to better reflect the complexities of human tumors. Traditionally, immunocompetent and immunodeficient mice with syngeneic and xenografted tumors transplanted subcutaneously or orthotopically have been used. These models are still being widely employed for many different types of studies, in part due to their widespread availability and low cost. Other types of mouse models used in cancer research comprise transgenic mice in which oncogenes can be constitutively or conditionally expressed and tumor-suppressor genes silenced using conventional methods, such as retroviral infection, microinjection of DNA constructs, and the so-called "gene-targeted transgene" approach. These traditional transgenic models have been very important in studies of carcinogenesis and tumor pathogenesis, as well as in studies evaluating the development of resistance to therapy. Recently, the clustered regularly interspaced short palindromic repeats (CRISPR)-based genome editing approach has revolutionized the field of mouse cancer models and has had a profound and rapid impact on the development of more effective systems to study human cancers. The CRISPR/Cas9-based transgenic models have the capacity to engineer a wide spectrum of mutations found in human cancers and provide solutions to problems that were previously unsolvable. Recently, humanized mouse xenograft models that accept patient-derived xenografts and CD34+ cells were developed to better mimic tumor heterogeneity, the tumor microenvironment, and cross-talk between the tumor and stromal/immune cells. These features make them extremely valuable models for the evaluation of investigational cancer therapies, specifically new immunotherapies. Taken together, improvements in both the CRISPR/Cas9 system producing more valid mouse models and in the humanized mouse xenograft models resembling complex interactions between the tumor and its environment might represent one of the successful pathways to precise individualized cancer therapy, leading to improved cancer patient survival and quality of life.

Humanized Rodent Models for Cancer Research

Patient-derived Human Tumour Tissue Xenografts in Immunodeficient Mice: a Systematic Review

Development of humanized mouse with patient‐derived xenografts for cancer immunotherapy studies: A comprehensive review

Human Immune System Mice With Autologous Tumor for Modeling Cancer Immunotherapies

Experimental mouse models for translational human cancer research

Humanized mouse models for immuno-oncology research

Humanized Mouse Models for Immuno-oncology Drug Discovery

Transgenic Mouse Models in Cancer Research

Mouse Tumor Models for Advanced Cancer Immunotherapy

Technical considerations and strategies for generating and optimizing humanized mouse tumor models in immuno-oncology research

Humanized NOD-SCID IL2rg–/– mice as a preclinical model for cancer research and its potential use for individualized cancer therapies.

Modeling the Tumor Microenvironment and Cancer Immunotherapy in Next-Generation Humanized Mice

The establishment, application and challenge of the humanized mice

Human tumor xenografts in mouse as a model for evaluating therapeutic efficacy of monoclonal antibodies or antibody-drug conjugate targeting receptor tyrosine kinases.

Mouse models in oncoimmunology

[Application and Recent Advances of Laboratory Mouse in Human Cancer Research].

Mouse Models for Head and Neck Squamous Cell Carcinoma

Mouse models with human immunity and their application in biomedical research.

Mouse Models with Human Immunity and Their Application in Biomedical Research

Models of breast cancer: quo vadis, animal modeling?

Translation Potential and Challenges of In Vitro and Murine Models in Cancer Clinic